Press Release Forum [] Forum Index

Press Release Forum []
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!


Cancer Drugs R&D conference

Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases
View previous topic :: View next topic  
Author Message

Joined: 03 May 2007
Posts: 20

PostPosted: Wed Dec 19, 2007 8:52 pm    Post subject: Cancer Drugs R&D conference Reply with quote

MONROVIA, CA – Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix.

Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug discovery.

Oncology drug discovery at GlaxoSmithKline is focused on molecularly targeted therapeutics for the treatment of cancer and for cancer supportive care indications. A guiding principle of the company’s approach is that a detailed, mechanistic understanding of pathobiology and of drug action – at the molecular, cellular and organismal level – is essential for effective drug discovery. Towards this end GlaxoSmithKline has built a discovery organization that encompasses robust biochemical, cellular biological and in vivo pharmacological interrogation of drug candidates. Examples of the application of these approaches to several cancer drug-seeking efforts will be presented at the conference.

Jeffrey Hanke, Vice President of Cancer Research at AstraZeneca, will also give a keynote presentation.

Dr. Hanke will present on developing new therapeutics for the treatment of cancer. He will discuss challenges and opportunities within the field of cancer drugs.

AstraZeneca’s cancer discovery research operations are considered a top priority within the company. AstraZeneca also focuses on novel approaches to cancer prevention and therapy. The company is optimistic about future compounds and drugs for the treatment of cancer.

The 5th Cancer Drugs Research & Development conference features presentations on the successes and setbacks of modern cancer drugs, new drug compounds and future drugs for the treatment and prevention of cancer, cancer drug development in clinical trials and new drug delivery methods. For more information, visit


GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
Back to top
View user's profile Send private message Send e-mail
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases All times are GMT - 4 Hours
Page 1 of 1

Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release


Editor's pick: